Is Pulmonx Corp (LUNG) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 67.8% / 30% | 121.8% / 30% | 16.6% / 30% | 6.04% / 5% | ✗ NOT HALAL |
| DJIM | 67.8% / 33% | 121.8% / 33% | 16.6% / 33% | 6.04% / 5% | ✗ NOT HALAL |
| MSCI | 34.7% / 33% | 62.3% / 33% | 8.5% / 33% | 6.04% / 5% | ✗ NOT HALAL |
| S&P | 67.8% / 33% | 121.8% / 33% | 16.6% / 33% | 6.04% / 5% | ✗ NOT HALAL |
| FTSE | 34.7% / 33% | 62.3% / 33% | 8.5% / 50% | 6.04% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 74.2% | |
| Operating Margin | -43.8% | |
| Net Margin | -59.7% | |
| Return on Equity (ROE) | -77.2% | |
| Return on Assets (ROA) | -23.0% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$32M |
| Free Cash Flow | -$33M |
| Total Debt | $56M |
| Debt-to-Equity | 104.2 |
| Current Ratio | 5.1 |
| Total Assets | $129M |
Price & Trading
| Last Close | $1.24 |
| 50-Day MA | $1.58 |
| 200-Day MA | $1.94 |
| Avg Volume | 490K |
| Beta | 0.1 |
|
52-Week Range
$1.14
| |
About Pulmonx Corp (LUNG)
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Pulmonx Corp (LUNG) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Pulmonx Corp is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Pulmonx Corp's debt ratio?
Pulmonx Corp's debt ratio is 67.8% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 34.7%.
What are Pulmonx Corp's key financial metrics?
Pulmonx Corp has a market capitalization of $49M, and revenue of $90M. The company maintains a gross margin of 74.2% and a net margin of -59.7%. Return on equity stands at -77.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.